1 / 8

Dengue Vaccine Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 and Forecast

Dengue fever is also known as break bone fever, it is a mosquito born and endemic disease that leads to severe flu like illness. Dengue caused by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by several mosquito species of the Aedes type, mainly by A. aegypti. Symptoms include fever, muscle and joint pains, headache vomiting, and characteristic skin rash. With proper treatment, dengue patient can recover from the infection within seven days. However, in some cases, it may lead to life threatening dengue hemorrhagic fever. Dengue virus has five different types of strains, infection with one strain of dengue virus usually gives lifelong immunity to that type. Subsequent infection with a different type of dengue virus increases the risk of severe complications.

saikrishna
Download Presentation

Dengue Vaccine Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 and Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Dengue Vaccine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016 and Forecast 2017-2023 ©2017 Precision BusinessInsights

  2. Dengue fever is also known as break bone fever, it is a mosquito born and endemic disease that leads to severe flu like illness. Dengue caused by RNA virus dengue belongs to the family Flaviviridae. Dengue is spread by several mosquito species of the Aedes type, mainly by A. aegypti. Symptoms include fever, muscle and joint pains, headache vomiting, and characteristic skin rash. With proper treatment, dengue patient can recover from the infection within seven days. However, in some cases, it may lead to life threatening dengue hemorrhagic fever. Dengue virus has five different types of strains, infection with one strain of dengue virus usually gives lifelong immunity to that type. Subsequent infection with a different type of dengue virus increases the risk of severe complications.Global dengue vaccine market is expected to grow over the forecast period owing to frequent incidences of dengue infections in tropical and sub-tropical regions, and increased government funding to develop vaccines. According to World Health Organization (WHO), 50 to 100 Mn dengue infections occur yearly. In addition, market players are actively involved in partnerships with NGO’s and government organisations, few vaccines are under clinical trials and rise in medical insurance in developing countries are anticipated to drive the market over the forecast period. However, lack or insufficient healthcare infrastructure in underdeveloped and developing regions leading to serious medical conditions going unnoticed. Furthermore, lack of awareness related to symptoms and high cost of vaccine development are hindering the dengue vaccine market.A sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-dengue-vaccine-market/#ulp-4H8Z4LpNMLEuOnnx ©2017 Precision BusinessInsights

  3. Dengue vaccine market segmented on the basis of vaccine type and end-userBased on vaccine type, dengue vaccine market is segmented intoLive- Attenuated VaccinesPurified Inactivated VaccinesBased on end-user, dengue vaccine market is segmented intoHospitalsClinicsOthersDengue vaccine market is expected to grow at a significant rate during the forecast period. Market players are focusing on the development of dengue vaccines which are in different stages of development to grab the market share. For instance, TDEN PIV, a tetravalent purified inactivated vaccine for prevention of dengue, currently being developed jointly by alter Reed Army Institute of Research (WRAIR) and GSK in phase -1 clinical study. Similarly, TDV is a live attenuated vaccine that is being developed in phase-3 clinical trials by Takeda Pharmaceuticals. Furthermore, many research institutions such as Bhutantan Institute, Griffith University are involved in development of dengue vaccine. Government and non-government organizations initiating many programs and activities to increase vaccines usage and awareness among the people.To view TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-dengue-vaccine-market/#ulp-c654SbFYO64MsOhu ©2017 Precision BusinessInsights

  4. Geographically dengue vaccine market segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East &Africa. North America dengue vaccine market is expected to show significant growth rate owing to new vaccine launches and growing awareness and government initiatives to prevent the dengue. In September 2016, Sanofi launched dengvaxia in Mexico for prevention of dengue. Asia Pacific region dengue vaccine market expected to grow at a high rate due to increase in dengue coupled with an increase in government funding for dengue vaccination. In April 2016, The Philippines government initiated vaccination program for prevention of dengue. South East Asia and Western Pacific regions are more seriously affected by dengue.Some of the market players in Dengue Vaccine Market include Sanofi (France), GlaxoSmithKline Plc (London), Takeda Pharmaceutical Company Ltd (Japan), Merck & Co Inc. (U.S.), InstitutoButantan (Brazil),  and VABIOTECH (Vietnam) to name a few.Need more information about this report @https://www.precisionbusinessinsights.com/market-reports/global-dengue-vaccine-market/#ulp-14mlyhjMGhVjZqa3 ©2017 Precision BusinessInsights

  5. Precision Business Insights is one of the leading market research and business consulting firm that follow a holistic approach to solve problems of the clients. We adopt and implement new research methodologies to achieve better results, help our clients by providing actionable insights and strategies to make better business decisions. We provide consulting, syndicated and customized market research services based on our clientneeds. • PBI’s mission is to provide high-quality market research reports and generate key insights to our clients. Our approachable strategies are help clients to make key decisions for business growth • PBI caters consulting services to the market players in various domains such as Biotechnology, Pharmaceuticals, Medical Devices, Chemical, Electronics and Electrical, Veterinary, Agriculture, Food and Beverages. We provide impeccable research reports in quick turnaroundtime. • Our logo represents what we do, Eagle in the logo represents the Precision as in the name of the company & its decision making skills and the hand shaking reflects the attitude of the team and how it work with its clients. Red represents passion, strength of the team and blue represents the depth of insightsit gives to clients • OurExpertise: • MarketIntelligence • Growth Strategies • CompetitiveBenchmarking • Custom MarketResearch • ConsultingServices • Company Profiles Precision Business Insights - AboutUs ©2017 Precision BusinessInsights

  6. ResearchMethodology ©2017 Precision BusinessInsights

  7. PBI 3 stepProcess Top DownApproach Primary Research 1st step –Collection of the relevantdata Secondary Research Research Methodology Paid and Free Databases 2nd step – Validating and quality checkof thedata Supply and DemandSide Analysis 3rd step – Collection of the data and drawing insights from thedata KeyInsights Bottom UpApproach ©2017 Precision BusinessInsights

  8. EuropeOffice: Precision BusinessInsights, Kemp House, 152 – 160 City Road, London EC1V2NX Toll Free :+1-866-598-1553 Email:sales@precisionbusinessinsights.com ©2017 Precision BusinessInsights

More Related